NAFDAC and National Counter Terrorism Centre Collaborate Against Counterfeit Drugs
NAFDAC Collaborates with National Counter Terrorism Centre
The National Agency for Food and Drug Administration and Control (NAFDAC) has taken significant steps to improve drug safety by entering into a Memorandum of Understanding (MoU) with the National Counter Terrorism Centre. This alliance aims to combat counterfeit drugs, a growing concern in the pharmaceutical sector.
Significance of the Collaboration
This collaboration is crucial for enhancing consumer protection and safeguarding public health. Counterfeit medications pose serious risks, and through this partnership, both organizations are committed to ensuring the integrity of the drug supply chain.
Key Objectives of the MoU
- Strengthening regulatory frameworks
- Enhancing intelligence sharing
- Promoting public awareness on the dangers of counterfeit drugs
This initiative marks a significant milestone in the ongoing battle against drug-related crimes.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.